Immune modulation following α and β- radionuclide therapy targeting fibroblast activation protein-α in a preclinical tumor model.
Saved in:
| Title: | Immune modulation following α and β- radionuclide therapy targeting fibroblast activation protein-α in a preclinical tumor model. |
|---|---|
| Authors: | Ceuppens H; Vrije Universiteit Brussel, Department of Biomedical Sciences, Translational Oncology Research Center, Laboratory for Molecular and Cellular Therapy, Brussels, Belgium., De Ridder K; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium., Ertveldt T; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium., Zeven K; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium., De Mey W; Vrije Universiteit Brussel, Department of Biomedical Sciences, Translational Oncology Research Center, Laboratory for Molecular and Cellular Therapy, Brussels, Belgium., Pombo Antunes AR; Precirix NV/SA, Brussels, Belgium., Navarro L; Precirix NV/SA, Brussels, Belgium., Dumauthioz N; Precirix NV/SA, Brussels, Belgium., Lahoutte T; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.; Precirix NV/SA, Brussels, Belgium.; Nuclear Medicine Department, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium., Debacker JM; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.; Nuclear Medicine Department, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium., Devoogdt N; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium., Keyaerts M; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.; Nuclear Medicine Department, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium., D'Huyvetter M; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium.; Precirix NV/SA, Brussels, Belgium., Goyvaerts C; Vrije Universiteit Brussel, Molecular Imaging and Therapy Research Group, Brussels, Belgium., Breckpot K; Vrije Universiteit Brussel, Department of Biomedical Sciences, Translational Oncology Research Center, Laboratory for Molecular and Cellular Therapy, Brussels, Belgium. |
| Source: | Oncoimmunology [Oncoimmunology] 2025 Dec; Vol. 14 (1), pp. 2540054. Date of Electronic Publication: 2025 Aug 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2162-402X |
|---|---|
| DOI: | 10.1080/2162402X.2025.2540054 |
